BSEAGM/EGM1d ago · 1 Oct 2026, 07:17 pm

Attached

Novelix Pharmaceuticals Ltd · 536565

✦ AI SummaryMgmt Change

Novelix Pharmaceuticals Ltd has announced the voting results of its 32nd Annual General Meeting (AGM), which was held on September 30, 2026. The meeting was conducted through video conferencing, and the voting results have been disclosed in accordance with Regulation 44(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The resolutions passed include the adoption of the standalone financial statements for the financial year ended March 31, 2026, and the appointment of a new whole-time director.

Analysis Scores

Earnings Impact2/10
Growth Catalyst3/10
Governance Concern2/10
Regulatory Risk1/10
Balance Sheet Risk2/10
Liquidity Impact5/10
Market Sentiment4/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Novelix Pharmaceuticals Ltd - 536565 - Shareholders Meeting- Voting Results

Attachments (1)

📄

d832ad1d-02fc-4ef0-b50d-e144b7b8a2cd.pdf

pdf

Download →
View document text
;f^*ffi*(ffi,m* 0l't October, 2026 The Deputy Manager (Department of Corporate Affairs) BSE Limited Phiroze Jeejeebhoy Towers, Dalal Street. Fort Mumbai- 400023 Sub: Voting Results and Scrutinizers' Report of the 32nd Annual General Meeting (AGM) held on Wednesday 30tb September, 2026. Ref: Scrip Code: 536565 ld: NOVI l,IX Dear Sir/ Madam, with reference to the above captioned subject this is to inform you that the 32'd Annual General Meeting (AGM) of the members of Novelix Pharmaceuticals Limited was held on Wednesday, 3Oth September 2026 at 03:00 P.M. (1ST") through Video Conferencing ("VC")/ Other Audio- Visual Means C'OAVM). The business of the meeting was transacted electronically. As required under Regulation 44 (3) ol SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are lumishing herewith the Combined Voting Result (i.e., result of remote e-voting prior to the AGM and e-voting conducted at the AGM) along with Consolidated Scrutiniser's Report thereon. The Voting Results have also been uploaded in XBRL format on BSE portal. We request you to kindly take a note ofthe same on your records. Thanking you. Yours sincerely For Novelix Pharmaceuticals Venkateshwarlu Pulluru (Whole-time director) DIN: 02076871 Novelix Pharmaceuticals limited (Formerly Known as TRIMURTHI LlMlTE0) H No:3-6 2j7/61o, Flat No: 610, 6rh Floor, Lingapur LA Builders, Also Known as Amrutha Estates, Himayat Nagar, Hyderabad, Telangana- 5ooo29 Ph No: +91 89776)1044 EmaiL novelixpharmaceuticals@gmail-com www.novelixpharma.com #nffi*lffi,W* DETATLS OF VOTTNG RESULTS AS pER REGULATTON 44(3) OF THE SEBI (LISTING OBLIGATIONS AND DISCLOSURE NTQUINBM'TNTS) (LODR) REGULATIONS,20IS Date of the AGM: September 30, 2026 Total number of shareholders (as on cutoff date i.e., 23_09_2026): 32gg No. of shareholders present in the meeting either in person or through proxy: Promoters and Promoter Group :0 Public :0 No. of Shareholders attended the meeting through Video Conferencing Promoters and Promoter Group :3 Public :70 Novelix pharmaceuticals limited (Formerly Known as TRIMURTHt LtMITED) H No: l-6'217/6ro, Flat No: 61o, 6rh Froor, Lingapur LA Buirders, Arso Known as Amrutha Estates, Himayat Nagar, Hyderabad, Telangana- 5ooo29 ph No: +9r 99776)1.,44 Emairt noverixpharmaceuticars@gmair-com www.novelixpharma.com Resolution (1) Resolution required: (Ordinary / Special) Ordinary Whether promoter/promoter group are No interested in the agenda/resolution? Description of resolution considered To receive, consider and adopt: The standalone financial statements of the Company which includes the Audited Balance Sheet as at March 37,2026, the Statement of Profit and Loss for the financial year ended as on that date and the Cash Flow Statement together with reports of the Board of Directors and the Statutory Auditors thereon. Category Mode of No. of No. of % of Votes No. of No. of % of votes in % of Votes voting shares votes polled on votes - in votes favour on votes against on votes held polled outstanding favour polled polled shares against (1) \2) (3)=t(2)/(1)1.100 (4) (s) (6)= (4)/(2 )l* 100 (7)=(s)/(2)l* 100 Promoter E-Voting 1.54517 33 1,4832733 95.9567 1,4832133 0 100 0 Poll 0 0 0 0 0 0 Promoter Postal 0 0 0 0 0 0 G roup Ballot (if applicable) Total 754577 33 748327 33 95.9567 74832733 0 100 0 Public- E-Voting 0 0 0 0 0 0 0 lnstitutions Po ll 0 0 0 0 0 0 Postal 0 0 0 0 0 0 Ballot (if applicable) Total 0 0 0 0 0 0 0 Public' E-Voting 13012267 41,1927I 31.6569 41,73268 6010 99.8541 0.1459 Poll 0 0 0 0 0 0 lnstitutions Postal 0 0 0 0 0 0 Ballot {if applicable) Total 73012267 4),79278 31.6569 4773268 6010 99.8541 0.1459 Total 28470000 18952011 66.5684 18946001 6010 99.9683 0.0317 Whether resolution is Pass or Not. Yes Disclosure of notes on resolution Resolution (2) Resolution required: (Ordinary / Special) Ordinary Whether promoter/promoter group are Yes interested in the agenda/resolution? Description of resolution considered To appoint a director in place of Ms. Sridevi Belide (DlN: 10455373), Non- Executive Directoi who retires by rotation, and being eligible, has offered herself for re-appointment. Category Mode of No. of No. of % of Votes No. of No. of % of votes in % of Votes voting shares votes polled on votes - in votes favour on votes against on votes held polled outstanding favou r poiled poiled shares against (1) (2) (3)=t(2)/(1)l.1oo (4) (s) (6)= t(4)/(2 )1.100 (7)=t(s)/(2)l'* 100 .14832733 Promoter E'Voting 154577 33 95.9567 14832133 0 100 0 Poll 0 0 0 0 0 0 Promoter Postal o o 0 o o o Group Ballot (if applicable) Total 1,54577 33 1,48327 33 95.9567 1,4832733 0 100 0 Public- E-VotinB 0 0 0 0 0 0 0 lnstitutions Poll 0 0 0 0 0 0 Postal 0 0 0 0 0 0 Ballot (if applicable) Total 0 0 0 0 0 0 0 Public- E-Voting 13072267 471927a 31.6569 4113268 6010 99.8541 0.1459 Poll 0 0 o o 0 0 lnstitu tio n s Postal 0 0 0 0 0 0 Ballot (if applicable) Total 1,3072267 41,1,927 8 31.6569 4173264 6010 99.8541 0.1459 Total 28470000 18952011 66.5684 18946001 6010 99.9683 0.0317 Whether resolution is Pass or Not. Yes Disclosure of notes on resolution Resolution (3) Resolution required: (Ordinary / Special) Special Whether promoter/promoter group are Yes interested in the agenda/resolution? Description of resolution considered Appointment of Mr. Gnana Prakash Gattu (DlN:00517921) as Whole Time Director of the Company Category Mode of No. of No. of % of Votes No. of No. of % of votes in % of Votes voting shares votes polled on votes - in votes favour on votes against on votes held polled outstanding favour polled polled shares against {1) 12) (3)=J(2)/11)l+100 {4) (s) l6)-u4y I2D* 100 (7)=usyl2D* 1oo Promoter E-Voting 154577 33 ).4832733 95.9567 1,4832733 0 100 0 and Poll 0 0 0 0 0 0 Promoter Postal 0 0 0 0 0 0 Group Ballot (if applicable) Total 15457733 14832133 95.9567 74432733 0 100 0 Pu blic- E-Voting 0 0 0 0 0 0 0 I n stit utio n s Poll 0 0 0 0 0 0 Postal 0 0 0 0 0 0 Ballot (if applicable) Tota I 0 0 0 0 0 0 0 Public- E Votjng 1,3012267 41,19278 31.6569 4.J,1,3268 6010 99.8541 0.1459 Non Poil 0 0 0 0 0 0 lnstitutions Postal 0 0 0 0 0 0 Ballot (if applicable) Total 73072261 41,79278 31.6569 4113268 6010 99.8541 0.1459 Total 28470000 189s2011 66.5684 18946001 6010 99.9683 0.0317 Whether resolution is Pass or Not. Yes Disclosure of notes on resolution BHARAT KHANIWAL & CO. CO M PA NY SE CR E T AR I ES Address: Plot No. 44, Prem Sagar, Bhankrota, Jaipur, Rajasthan 302026 MobileNo.: +91 93526 79700 E-mail: cskhaniwalb@gmail.com Consolidated Report of Scrutinizer on Remote e-voting & e-voting at the AnnualGeneral Meeting [Pursuant to the provisions of Section 108 of the Companies Act, 2013 read with Rule 20 of the Companies (Management and Administration) Rules, 2014 (as amended) and Regulation 44 of SEBI (Listing Obligations & Disclosure Requirements) Regulations 2015] Dated: 01stOctober, 2026 The Chairman, Novelix Pharmaceuticals Limited Formerly Known asFormerly known as Trimurthi Limited H No: 3-6-237/610, Flat No: 610, 6Th Floor, Lingapur LA Builders, Also Known as Amrutha Estates, Himayat Nagar, Hyderabad, Telangana-500029 Re.: 32nd Annual General Meeting of Novelix Pharmaceuticals Limited held on Wednesday, 30th September, 2026at 3:00 P.M. through video conferencing ('VC') / other audio-visual means ('OAVM'). Subject: Report on Remote e-voting & e-voting at the Annual General Meeting. Dear Sir, I, Bharat Khaniwal, PracticingCompany Secretaries, holding Membership Number 29035and Certificate of Practice Number 27989, Proprietor of M/s Bharat Khaniwal & Co., Company Secretaries, had been appointed as the Scrutinizer by the Board of Directors of Novelix Pharmaceuticals Limited pursuant to Section 108 of the Companies Act, 2013 ("the Act") read with Rule 20 of the Companies (Management and Administration) Rules, 2014, as amended, to conduct the remote e-voting process in respect of the below mentioned resolutions proposed at the32ndAnnual General Meeting ("AGM") of Novelix Pharmaceut [Showing first 8,000 characters — download PDF for full document]